174 related articles for article (PubMed ID: 11134031)
1. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase.
Anderson JA; Fredenburgh JC; Stafford AR; Guo YS; Hirsh J; Ghazarossian V; Weitz JI
J Biol Chem; 2001 Mar; 276(13):9755-61. PubMed ID: 11134031
[TBL] [Abstract][Full Text] [Related]
2. Antithrombin-independent anticoagulation by hypersulfated low-molecular-weight heparin.
Fredenburgh JC; Anderson JA; Weitz JI
Trends Cardiovasc Med; 2002 Oct; 12(7):281-7. PubMed ID: 12458089
[TBL] [Abstract][Full Text] [Related]
3. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
4. Depolymerized holothurian glycosaminoglycan and heparin inhibit the intrinsic tenase complex by a common antithrombin-independent mechanism.
Sheehan JP; Walke EN
Blood; 2006 May; 107(10):3876-82. PubMed ID: 16672689
[TBL] [Abstract][Full Text] [Related]
5. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex.
Sheehan JP; Lan HC
Blood; 1998 Sep; 92(5):1617-25. PubMed ID: 9716589
[TBL] [Abstract][Full Text] [Related]
6. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Sheehan JP; Kobbervig CE; Kirkpatrick HM
Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
Buyue Y; Misenheimer TM; Sheehan JP
J Thromb Haemost; 2012 Oct; 10(10):2086-98. PubMed ID: 22905983
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of inhibition of the prothrombinase complex by a covalent antithrombin-heparin complex.
Stevic I; Berry LR; Chan AK
J Biochem; 2012 Aug; 152(2):139-48. PubMed ID: 22518847
[TBL] [Abstract][Full Text] [Related]
9. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate.
Glauser BF; Pereira MS; Monteiro RQ; Mourão PA
Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257
[TBL] [Abstract][Full Text] [Related]
10. Covalently linking heparin to antithrombin enhances prothrombinase inhibition on activated platelets.
Stevic I; Chan HH; Chander A; Berry LR; Chan AK
Thromb Haemost; 2013 Jun; 109(6):1016-24. PubMed ID: 23494009
[TBL] [Abstract][Full Text] [Related]
11. Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.
Wood JP; Baumann Kreuziger LM; Desai UR; Mast AE
Br J Haematol; 2016 Oct; 175(1):123-32. PubMed ID: 27301751
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the prothrombinase complex on red blood cells by heparin and covalent antithrombin-heparin complex.
Stevic I; Chan HH; Berry LR; Chander A; Chan AK
J Biochem; 2013 Jan; 153(1):103-10. PubMed ID: 23100269
[TBL] [Abstract][Full Text] [Related]
14. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
15. HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.
Kretz CA; Cuddy KK; Stafford AR; Fredenburgh JC; Roberts R; Weitz JI
Thromb Haemost; 2010 Jan; 103(1):83-93. PubMed ID: 20062917
[TBL] [Abstract][Full Text] [Related]
16. Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.
Li J; Li S; Yan L; Ding T; Linhardt RJ; Yu Y; Liu X; Liu D; Ye X; Chen S
Eur J Med Chem; 2017 Oct; 139():191-200. PubMed ID: 28800457
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
Lin P; Sinha U; Betz A
Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by heparin of the human blood coagulation intrinsic pathway factor X activator.
Barrow RT; Parker ET; Krishnaswamy S; Lollar P
J Biol Chem; 1994 Oct; 269(43):26796-800. PubMed ID: 7929416
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography. Comparison with unfractionated heparin and low-molecular-weight heparin.
Atkinson HM; Mewhort-Buist TA; Berry LR; Chan AK
Thromb Haemost; 2009 Jul; 102(1):62-8. PubMed ID: 19572069
[TBL] [Abstract][Full Text] [Related]
20. The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma.
Bendetowicz AV; Bara L; Samama MM
Thromb Res; 1990 Jun; 58(5):445-54. PubMed ID: 2164262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
